15.11.2021 Limes Schlosskliniken AG  DE000A0JDBC7

DGAP-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG


DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Takeover/Takeover
Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG

15-Nov-2021 / 11:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP-Adhoc: LIMES Schlosskliniken AG:

LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG

LIMES Schlosskliniken AG, Cologne/Zurich, 15.11.2021. LIMES Schlosskliniken AG acquired 51% of the Swiss PRC Group AG. The remaining 49% will be held by the management of the company.

PRC Group AG runs the world's most exclusive, individual and discreet clinic for addiction and mental health treatments under the brand "Paracelsus Recovery". With teams of 15 doctors and therapists per patient, the clinic treats mainly affluent international patients and celebrity clients.

PRC and LIMES would like to significantly expand the treatment options for international clients. The merger provides the best conditions for this strategy.

The Paracelsus Recovery clinic plans to achieve sales of EUR 8 million and an operating result (EBITDA) of EUR 2.5 million in 2022. The clinic will contribute earnings per share of EUR 4.2 to LIMES consolidated net income after minority interests.

The transaction is financed from liquid funds of the LIMES Group as well as shareholder loans.

Company profiles:

Paracelsus Recovery was founded in 2013 as a family-owned clinic and has established itself as the world's leading clinic for addiction and mental illness. Besides its base in Zürich, since 2019 the clinic also treats patients in London. Furthermore, the clinic sends individual therapists and whole teams to support patients worldwide in their homes. The exclusive treatment offers are catering to an affluent international clientele such as business owners, top executives and public figures, as well as their family members, who seek not only the best possible and most intensive treatment options, but require strict confidentiality and a luxurious environment. More information can be found at www.paracelsus-recovery.com.

The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.

Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Tel.: 02203 / 29014-202, [email protected], www.limes-schlosskliniken.de

Language: English
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Köln, Germany
Stock exchange Düsseldorf Freiverkehr, Primärmarkt, XETRA

End of the message

15-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Listed: Regulated Unofficial Market in Dusseldorf
EQS News ID: 1249037

End of Announcement DGAP News Service

1249037  15-Nov-2021 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 6,54 7,43 8,18 11,02 23,44 28,81 37,17
EBITDA1,2 -0,49 -0,13 0,26 0,84 6,02 8,65 7,67
EBITDA-Marge3 -7,49 -1,75 3,18 7,62 25,68 30,02
EBIT1,4 -0,72 -0,93 -0,54 -0,43 4,53 6,00 5,03
EBIT-Marge5 -11,01 -12,52 -6,60 -3,90 19,33 20,83 13,53
Jahresüberschuss1 -1,25 -1,46 -0,83 -0,69 4,11 4,86 3,91
Netto-Marge6 -19,11 -19,65 -10,15 -6,26 17,53 16,87 10,52
Cashflow1,7 1,02 -0,66 0,17 0,76 4,77 8,04 6,29
Ergebnis je Aktie8 -4,95 -5,78 -2,81 -2,37 13,45 14,34 11,58
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: B-S-H Collegen

Limes Schlosskliniken
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0JDBC 334,000 Kaufen 97,93
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
19,76 21,46 0,92 71,14
6,47 15,56 2,63 12,97
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
0,00 0,00 0,00 10.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
03.09.2024 13.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,53% 10,46% 17,61% -1,76%
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Limes Schlosskliniken AG  ISIN: DE000A0JDBC7 können Sie bei EQS abrufen

Pflegeeinrichtungen , A0JDBC , LIK , XETR:LIK